BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hazlitt RA, Min J, Zuo J. Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss. J Med Chem 2018;61:5512-24. [PMID: 29361217 DOI: 10.1021/acs.jmedchem.7b01653] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen CH, Huang CY, Lin HH, Wang MC, Chang CY, Cheng YF. Association of Sodium Thiosulfate With Risk of Ototoxic Effects From Platinum-Based Chemotherapy: A Systematic Review and Meta-analysis. JAMA Netw Open 2021;4:e2118895. [PMID: 34338793 DOI: 10.1001/jamanetworkopen.2021.18895] [Reference Citation Analysis]
2 Hu B, Liu Y, Chen X, Zhao J, Han J, Dong H, Zheng Q, Nie G. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo. Biochem Biophys Res Commun 2020;533:1442-8. [PMID: 33109343 DOI: 10.1016/j.bbrc.2020.10.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kühl A, Dixon A, Hali M, Apawu AK, Muca A, Sinan M, Warila J, Braun RD, Berkowitz BA, Holt AG. Novel QUEST MRI In Vivo Measurement of Noise-induced Oxidative Stress in the Cochlea. Sci Rep 2019;9:16265. [PMID: 31700007 DOI: 10.1038/s41598-019-52439-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Rybak LP, Mukherjea D, Ramkumar V. Mechanisms of Cisplatin-Induced Ototoxicity and Prevention. Semin Hear 2019;40:197-204. [PMID: 31036996 DOI: 10.1055/s-0039-1684048] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 15.5] [Reference Citation Analysis]
5 Chen Y, Gu J, Liu J, Tong L, Shi F, Wang X, Wang X, Yu D, Wu H. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity. Int J Nanomedicine 2019;14:4211-27. [PMID: 31239676 DOI: 10.2147/IJN.S195336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
6 Capper MS, Enriquez Garcia A, Lai B, Wang BO, Gelfand BS, Shemanko CS, Jalilehvand F. The effect of sodium thiosulfate on cytotoxicity of a diimine Re(I) tricarbonyl complex. Dalton Trans 2021;50:5968-77. [PMID: 33949526 DOI: 10.1039/d1dt00517k] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gentilin E, Simoni E, Candito M, Cazzador D, Astolfi L. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets. Trends in Molecular Medicine 2019;25:1123-32. [DOI: 10.1016/j.molmed.2019.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
8 Wang X, Chen Y, Tao Y, Gao Y, Yu D, Wu H. A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss. Int J Nanomedicine 2018;13:7517-31. [PMID: 30532536 DOI: 10.2147/IJN.S170130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
9 Sun C, Yao Y, Zhang C, Tong D, Xie B. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway. Otology & Neurotology 2019;40:965-71. [DOI: 10.1097/mao.0000000000002288] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Ingersoll MA, Malloy EA, Caster LE, Holland EM, Xu Z, Zallocchi M, Currier D, Liu H, He DZZ, Min J, Chen T, Zuo J, Teitz T. BRAF inhibition protects against hearing loss in mice. Sci Adv 2020;6:eabd0561. [PMID: 33268358 DOI: 10.1126/sciadv.abd0561] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wong Y, Lin M, Liu P, Ko J, Huang G, Tu D, Ou C. D‐methionine improves cisplatin‐induced anorexia and dyspepsia syndrome by attenuating intestinal tryptophan hydroxylase 1 activity and increasing plasma leptin concentration. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13803] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Hazlitt RA, Teitz T, Bonga JD, Fang J, Diao S, Iconaru L, Yang L, Goktug AN, Currier DG, Chen T, Rankovic Z, Min J, Zuo J. Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss. J Med Chem 2018;61:7700-9. [PMID: 30091915 DOI: 10.1021/acs.jmedchem.8b00669] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
14 Kros CJ, Steyger PS. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies. Cold Spring Harb Perspect Med 2019;9:a033548. [PMID: 30559254 DOI: 10.1101/cshperspect.a033548] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
15 Teitz T, Fang J, Goktug AN, Bonga JD, Diao S, Hazlitt RA, Iconaru L, Morfouace M, Currier D, Zhou Y, Umans RA, Taylor MR, Cheng C, Min J, Freeman B, Peng J, Roussel MF, Kriwacki R, Guy RK, Chen T, Zuo J. CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. J Exp Med 2018;215:1187-203. [PMID: 29514916 DOI: 10.1084/jem.20172246] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
16 Rybak LP, Dhukhwa A, Mukherjea D, Ramkumar V. Local Drug Delivery for Prevention of Hearing Loss. Front Cell Neurosci 2019;13:300. [PMID: 31338024 DOI: 10.3389/fncel.2019.00300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
17 Pak JH, Kim Y, Yi J, Chung JW. Antioxidant Therapy against Oxidative Damage of the Inner Ear: Protection and Preconditioning. Antioxidants (Basel) 2020;9:E1076. [PMID: 33147893 DOI: 10.3390/antiox9111076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Stanford JK, Morgan DS, Bosworth NA, Proctor G, Chen T, Palmer TT, Thapa P, Walters BJ, Vetter DE, Black RD, Rogers LL, Spankovich C. Cool OtOprotective Ear Lumen (COOL) Therapy for Cisplatin-induced Hearing Loss. Otol Neurotol 2021;42:466-74. [PMID: 33351563 DOI: 10.1097/MAO.0000000000002948] [Reference Citation Analysis]
19 Fetoni AR, Paciello F, Troiani D. Cisplatin chemotherapy and cochlear damage: otoprotective and chemosensitization properties of polyphenols. Antioxid Redox Signal 2021. [PMID: 34731023 DOI: 10.1089/ars.2021.0183] [Reference Citation Analysis]
20 Zhang W, Xiong H, Pang J, Su Z, Lai L, Lin H, Jian B, He W, Yang H, Zheng Y. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production. Toxicol Lett 2020;331:1-10. [PMID: 32428544 DOI: 10.1016/j.toxlet.2020.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
21 Moos WH, Faller DV, Glavas IP, Harpp DN, Irwin MH, Kanara I, Pinkert CA, Powers WR, Steliou K, Vavvas DG, Kodukula K. A New Approach to Treating Neurodegenerative Otologic Disorders. Biores Open Access 2018;7:107-15. [PMID: 30069423 DOI: 10.1089/biores.2018.0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]